- Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Seminars in arthritis and rheumatism. 2015 Academic Article GET IT
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
Arthritis care & research.
Times cited: 34
Updated treatment algorithm of pulmonary arterial hypertension.
Journal of the American College of Cardiology.
Times cited: 286